Suppr超能文献

源自海洋来源物种的奥斯特利德衍生物及其细胞毒性和ADME/TOPKAT性质的评估。

Austalide derivative from marine-derived sp. and evaluation of its cytotoxic and ADME/TOPKAT properties.

作者信息

Elnaggar Mohamed S, Elissawy Ahmed M, Youssef Fadia S, Kicsák Máté, Kurtán Tibor, Singab Abdel Nasser B, Kalscheuer Rainer

机构信息

Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University Abbassia 11566 Cairo Egypt

Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-Universität Düsseldorf 40225 Germany.

出版信息

RSC Adv. 2023 Jun 1;13(24):16480-16487. doi: 10.1039/d3ra02632a. eCollection 2023 May 30.

Abstract

In-depth chemical investigation of an ethyl acetate extract of sp. isolated from the soft coral species resulted in the isolation of one new meroterpenoid, austalide Z (1), one known austalide W (2), six known prenylated indole diketopiperazine alkaloids (3-8), and phthalic acid and its ethyl derivative (9-10). The structures were established by means of 1D and 2D NMR (one- and two-dimensional nuclear magnetic resonance) experiments supported by UV analysis and ESI-MS (electrospray ionization mass spectrometry). cytotoxic evaluation was performed against the Caco-2 cancer cell line using the MTT assay, which showed that the examined compounds had weak to moderate activities, with the new meroterpenoid austalide Z (1) displaying an IC value of 51.6 μg mL. ADME/TOPKAT (absorption, distribution, metabolism, excretion, and toxicity) predication performed showed that most of the isolated compounds possessed reasonable pharmacokinetic, pharmacodynamic, and toxicity properties. Thus, it can be concluded that sp. could act as a source of drug leads for cancer prevention with promising pharmacokinetic and pharmacodynamic properties and thus could be incorporated in pharmaceutical dosage forms.

摘要

对从软珊瑚物种中分离出的[物种名称未给出]的乙酸乙酯提取物进行深入的化学研究,结果分离出一种新的半萜类化合物,澳他利德Z(1),一种已知的澳他利德W(2),六种已知的异戊烯基化吲哚二酮哌嗪生物碱(3 - 8),以及邻苯二甲酸及其乙酯衍生物(9 - 10)。通过一维和二维核磁共振(1D和2D NMR)实验,并辅以紫外分析和电喷雾电离质谱(ESI - MS)确定了其结构。使用MTT法对Caco - 2癌细胞系进行细胞毒性评估,结果表明所检测的化合物具有弱至中等活性,新的半萜类化合物澳他利德Z(1)的IC值为51.6 μg/mL。所进行的吸收、分布、代谢、排泄和毒性(ADME/TOPKAT)预测表明,大多数分离出的化合物具有合理的药代动力学、药效学和毒性特性。因此,可以得出结论,[物种名称未给出]可作为具有良好药代动力学和药效学特性的癌症预防药物先导物来源,从而可纳入药物剂型中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aed/10233426/0ad9582ce817/d3ra02632a-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验